Insider Trading Alert - KMG, ALCO And CMPR Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 27, 2015, 82 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $945.00 to $3,999,999.00.

Highlighted Stocks Traded by Insiders:

KMG Chemicals (KMG) - FREE Research Report

Hatcher David L, who is 10% Owner at KMG Chemicals, sold 3,000 shares at $29.07 on May 27, 2015. Following this transaction, the 10% Owner owned 2.0 million shares meaning that the stake was reduced by 0.15% with the 3,000-share transaction.

The shares most recently traded at $30.03, up $0.96, or 3.18% since the insider transaction. Historical insider transactions for KMG Chemicals go as follows:

  • 4-Week # shares bought: 2,000
  • 4-Week # shares sold: 25,500
  • 12-Week # shares bought: 3,000
  • 12-Week # shares sold: 49,500
  • 24-Week # shares bought: 3,000
  • 24-Week # shares sold: 54,500

The average volume for KMG Chemicals has been 76,000 shares per day over the past 30 days. KMG Chemicals has a market cap of $341.2 million and is part of the basic materials sector and chemicals industry. Shares are up 51.1% year-to-date as of the close of trading on Wednesday.

KMG Chemicals, Inc., through its subsidiaries, engages in the manufacture, formulation, and distribution of specialty chemicals in the United States, Mexico, Canada, Europe, Israel, and Singapore. It operates in two segments, Electronic Chemicals and Wood Treating Chemicals. The stock currently has a dividend yield of 0.41%. The company has a P/E ratio of 48.7. Currently, there is 1 analyst who rates KMG Chemicals a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on KMG - FREE

TheStreet Quant Ratings rates KMG Chemicals as a buy. The company's strengths can be seen in multiple areas, such as its compelling growth in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, solid stock price performance and impressive record of earnings per share growth. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full KMG Chemicals Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Alico (ALCO) - FREE Research Report

Smith Ken, who is Shareholder at Alico, sold 100 shares at $49.00 on May 27, 2015. Following this transaction, the Shareholder owned 3,534 shares meaning that the stake was reduced by 2.75% with the 100-share transaction.

The shares most recently traded at $49.28, up $0.28, or 0.57% since the insider transaction. Historical insider transactions for Alico go as follows:

  • 4-Week # shares bought: 3.7 million
  • 4-Week # shares sold: 1,852
  • 12-Week # shares bought: 3.7 million
  • 12-Week # shares sold: 5,952
  • 24-Week # shares bought: 3.7 million
  • 24-Week # shares sold: 14,947

The average volume for Alico has been 17,300 shares per day over the past 30 days. Alico has a market cap of $408.7 million and is part of the consumer goods sector and food & beverage industry. Shares are down 1.3% year-to-date as of the close of trading on Tuesday.

Alico, Inc., together with its subsidiaries, operates as an agribusiness and land management company in the United States. The company operates in five segments: Citrus Groves, Improved Farmland, Ranch and Conservation, Agricultural Supply Chain Management and Support, and Other Operations. The stock currently has a dividend yield of 0.49%. The company has a P/E ratio of 26.0. Currently, there are no analysts who rate Alico a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ALCO - FREE

TheStreet Quant Ratings rates Alico as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat weak growth in earnings per share. Get the full Alico Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Cimpress (CMPR) - FREE Research Report

Blake Katryn, who is Pres, Vistaprint Business Unit at Cimpress, sold 739 shares at $81.90 on May 27, 2015. Following this transaction, the Pres, Vistaprint Business Unit owned 18,382 shares meaning that the stake was reduced by 3.86% with the 739-share transaction.

The shares most recently traded at $80.84, down $1.06, or 1.31% since the insider transaction. Historical insider transactions for Cimpress go as follows:

  • 4-Week # shares sold: 2,760
  • 12-Week # shares sold: 10,365
  • 24-Week # shares sold: 10,365

The average volume for Cimpress has been 248,500 shares per day over the past 30 days. Cimpress has a market cap of $2.6 billion and is part of the services sector and diversified services industry. Shares are up 8.69% year-to-date as of the close of trading on Wednesday.

Vistaprint N.V. operates as an online supplier of coordinated portfolios of marketing products and services to micro businesses worldwide. The company has a P/E ratio of 27.9. Currently, there are no analysts who rate Cimpress a buy, 1 analyst rates it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CMPR - FREE

TheStreet Quant Ratings rates Cimpress as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, notable return on equity, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Cimpress Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

3 Things Investors Must Know for Monday

3 Things Investors Must Know for Monday

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Street Stats: The Mid-Term Elections May Be a Rollercoaster Ride for Investors

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric